Intravenous immunoglobulin in drug and device refractory patients with the symptoms of gastroparesis—an open‐label study
Neurogastroenterology & Motility2017Vol. 30(3)
Citations Over TimeTop 14% of 2017 papers
Munish Ashat, Angela M. Lewis, Hammad Liaquat, Abigail Stocker, Lindsay McElmurray, V. Vedanarayanan, Kaartik Soota, Tiff Howell, Archana Kedar, Jonathan Obert, Thomas L. Abell
Abstract
Although limited by the absence of placebo group, the data illustrate the role of autoimmunity and neuromuscular evaluation in patients with gastroparesis and support the utility of a diagnostic trial of immunotherapy in an effort to improve therapeutic outcomes for such patients.
Related Papers
- → Gastric pacing is a new surgical treatment for gastroparesis(2001)179 cited
- → An 8-year review of barium studies in the diagnosis of gastroparesis(2007)29 cited
- → Targeting Treatment of Gastroparesis(2020)3 cited
- → Diabetic gastroparesis(2003)1 cited
- → Gastric Electrical Stimulation as a New Treatment Modality for Refractory Nausea and Vomiting with Normal Gastric Emptying(2023)